Risk with delayed anti-VEGF therapy in neovascular AMD

This is a discussion on the risk of vision loss for patients already on anti-VEGF therapy with neovascular AMD

Papers discussed
MARINA
PIER
EXCITE
loss to follow up
CATT reanalysis
Wills eye paper on vision loss and loss to follow up
Fight Retinal Blindness! paper on recurrence

Please see below on a CPD quiz - it has been approved by the New Zealand Optometric Board for 0.5 points under Clinical Diagnostic credits.